Li Changfei, Deng Mengmeng, Hu Jun, Li Xin, Chen Lizhao, Ju Ying, Hao Junli, Meng Songdong
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China.
School of Biomedical Sciences, Chengdu Medical College, Chengdu, China.
Oncotarget. 2016 Mar 29;7(13):17021-34. doi: 10.18632/oncotarget.7740.
Persistent inflammation in chronic hepatitis plays a major role in the development of hepatocellular carcinoma (HCC). In this study, the major inflammatory cytokines expressed in chronic hepatitis, IL-6 and TNF-α, induced a marked decrease in microRNA-122 (miR-122) levels, and miR-122 expression was downregulated in the livers of chronic hepatitis B (CHB) patients. The decrease of miR-122 caused upregulation of the proinflammatory chemokine CCL2. IL-6 and TNF-α suppressed miR-122 both by directly downregulating the transcription factor C/EBPα and indirectly upregulating c-myc, which blocks C/EBPα-mediated miR-122 transcription. In addition, IL-6 and TNF-α levels were elevated and miR-122 levels were decreased in mouse and rat models of diethylnitrosamine (DEN)-induced HCC. Restoration of miR-122 levels through delivery of agomir-122 suppressed DEN-induced hepatocarcinogenesis in mice. Our results show that inflammation-induced miR-122 downregulation in hepatitis contributes to carcinogenesis and suggest that increasing miR-122 may be an effective strategy for preventing HCC development in CHB patients.
慢性肝炎中的持续性炎症在肝细胞癌(HCC)的发生发展中起主要作用。在本研究中,慢性肝炎中表达的主要炎性细胞因子白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)导致微小RNA-122(miR-122)水平显著降低,且慢性乙型肝炎(CHB)患者肝脏中的miR-122表达下调。miR-122的减少导致促炎趋化因子CCL2上调。IL-6和TNF-α通过直接下调转录因子C/EBPα以及间接上调c-myc来抑制miR-122,而c-myc会阻断C/EBPα介导的miR-122转录。此外,在二乙基亚硝胺(DEN)诱导的HCC小鼠和大鼠模型中,IL-6和TNF-α水平升高而miR-122水平降低。通过导入agomir-122恢复miR-122水平可抑制DEN诱导的小鼠肝癌发生。我们的结果表明,肝炎中炎症诱导的miR-122下调促进了癌症发生,并提示增加miR-122可能是预防CHB患者发生HCC的有效策略。